ETF Building Blocks Channel Biotech ETF SBIO’s Momentum Strong to End 2023 By Nick Peters-GoldenDecember 28, 2023
ETF Building Blocks Channel Biotech ETF SBIO Sees Buy Signal Amid Hot Returns By Nick Peters-GoldenDecember 14, 2023
ETF Building Blocks Channel Play US Gene Treatment Approval in SBIO By Nick Peters-GoldenDecember 7, 2023
ETF Building Blocks Channel 3 Growth-Minded ETFs to Play Fed Rate Pause By Nick Peters-GoldenJune 13, 2023
Modern Alpha Channel Biden’s “Cancer Moonshot” Brings Biotech Focus Back to U.S. By Karrie GordonSeptember 15, 2022
ETF Building Blocks Channel Pfizer Vaccine Should Work Against Omicron, Just Less Efficiently By Karrie GordonNovember 30, 2021
Alternatives Channel Encouraging Election Year History for this Biotech ETF By Tom LydonSeptember 11, 2020
Nasdaq Investment Intelligence Channel New Biotech ETF Taps Into Small But Mighty Theme By Tom LydonAugust 6, 2020
ETF Building Blocks Channel When Innovation and Being Nimble Matters, Turn to this Biotech ETF By Tom LydonAugust 3, 2020
ETF Building Blocks Channel Fabulous Fundamentals Brighten Outlook for Healthcare, With This Biotech ETF By Tom LydonJuly 7, 2020
ETF Building Blocks Channel Another Round of Coronavirus Cases Puts This Biotech ETF in Focus By Tom LydonJune 29, 2020
Leveraged & Inverse Channel Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Thematic Investing Channel A Young Biotech ETF With Plenty of Potential By Todd ShriberSeptember 6, 2019
